Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-07
DOI
10.3389/fcell.2020.00584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
- (2020) Jermaine Goveia et al. CANCER CELL
- VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
- (2020) Eric Song et al. NATURE
- Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
- (2020) Yolla Haibe et al. Frontiers in Oncology
- Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis
- (2020) Katerina Rohlenova et al. Cell Metabolism
- The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression
- (2020) Oskar Ciesielski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
- (2020) Shamir Cassim et al. Cancers
- Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
- (2020) Poonam Sarode et al. Frontiers in Oncology
- Cancer‑associated fibroblast regulation of tumor neo‑angiogenesis as a therapeutic target in cancer (Review)
- (2019) Fang‑Tao Wang et al. Oncology Letters
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vessel co-option in cancer
- (2019) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
- (2019) Shuang Qin et al. Journal of Hematology & Oncology
- Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial
- (2019) Melanie Janning et al. INTERNATIONAL JOURNAL OF CANCER
- Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
- (2019) John D. Martin et al. Annual Review of Physiology
- Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study
- (2019) Anne Wolf et al. EMBO Molecular Medicine
- Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
- (2019) Brian I Rini et al. LANCET
- Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance
- (2019) Selma Maacha et al. Molecular Cancer
- Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
- (2019) Masahiro Shibata et al. Cancers
- Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
- (2019) Huiyan Cheng et al. Frontiers in Oncology
- Autophagy as a mechanism for anti-angiogenic therapy resistance
- (2019) Ankush Chandra et al. SEMINARS IN CANCER BIOLOGY
- Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma
- (2019) Eudocia Q. Lee et al. Cancer Medicine
- Drug resistance‑related sunitinib sequestration in autophagolysosomes of endothelial cells
- (2019) Shuang Wu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
- (2019) Wenqing Luan et al. OncoTargets and Therapy
- Tumor Endothelial Heterogeneity in Cancer Progression
- (2019) Nako Maishi et al. Cancers
- Vasohibin1, a new mouse cardiomyocyte IRES trans-acting factor that regulates translation in early hypoxia
- (2019) Fransky Hantelys et al. eLife
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma
- (2018) Robert J. Motzer et al. BRITISH JOURNAL OF CANCER
- Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis
- (2018) Liang Liu et al. CLINICAL CANCER RESEARCH
- Endothelial progenitor cells contribute to neovascularization of non-small cell lung cancer via histone deacetylase 7-mediated cytoskeleton regulation and angiogenic genes transcription
- (2018) Ye Wei et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer stem cells and hypoxia-inducible factors (Review)
- (2018) Wei-Wei Tong et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The PDGF/PDGFR pathway as a drug target
- (2018) Natalia Papadopoulos et al. MOLECULAR ASPECTS OF MEDICINE
- Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
- (2018) Arthur Winer et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular vesicles in cancer — implications for future improvements in cancer care
- (2018) Rong Xu et al. Nature Reviews Clinical Oncology
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Intermittent hypoxia induces a metastatic phenotype in breast cancer
- (2018) Anna Chen et al. ONCOGENE
- Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
- (2018) Joel P. Joseph et al. ORAL ONCOLOGY
- Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
- (2018) Rikke B. Holmgaard et al. Journal for ImmunoTherapy of Cancer
- Dual roles of endothelial FGF-2–FGFR1–PDGF-BB and perivascular FGF-2–FGFR2–PDGFRβ signaling pathways in tumor vascular remodeling
- (2018) Kayoko Hosaka et al. Cell Discovery
- The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
- (2018) Amit S. Yadav et al. Frontiers in Oncology
- Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth
- (2018) Victor LJL Thijssen et al. JOURNAL OF PATHOLOGY
- Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma
- (2018) Thomas Simon et al. Molecular Cancer
- Leukaemia hijacks a neural mechanism to invade the central nervous system
- (2018) Hisayuki Yao et al. NATURE
- Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma
- (2018) V. Desantis et al. Translational Oncology
- PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
- (2018) Tianrun Liu et al. Nature Communications
- Lenvatinib
- (2018) Koichi Suyama et al. Cancer Control
- Unravelling the Interplay between Extracellular Acidosis and Immune Cells
- (2018) Fernando Erra Díaz et al. MEDIATORS OF INFLAMMATION
- Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
- (2018) Gordon C. Jayson et al. Nature Communications
- Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
- (2017) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of PDGFs and PDGFRs in Colorectal Cancer
- (2017) Roberta M. Manzat Saplacan et al. MEDIATORS OF INFLAMMATION
- Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
- (2017) Daniel Delgado-Bellido et al. Molecular Cancer
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
- (2017) Lauren MacDonagh et al. Oncotarget
- Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
- (2017) Lothar C. Dieterich et al. Frontiers in Immunology
- Renal cell carcinoma
- (2017) James J. Hsieh et al. Nature Reviews Disease Primers
- Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy
- (2017) Seraina Faes et al. Cancers
- Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies
- (2016) Shiven B. Patel et al. Clinical Genitourinary Cancer
- Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
- (2016) Elizabeth A. Kuczynski et al. JNCI-Journal of the National Cancer Institute
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma
- (2016) Robert J Motzer et al. LANCET ONCOLOGY
- Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
- (2016) Toni K Choueiri et al. LANCET ONCOLOGY
- Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models
- (2016) S. Y. Park et al. MOLECULAR CANCER THERAPEUTICS
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
- (2016) Sophia Frentzas et al. NATURE MEDICINE
- 340 c-Met/β1 Integrin
- (2016) Maxim Sidorov et al. NEUROSURGERY
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents
- (2016) Beverly L. Falcon et al. PHARMACOLOGY & THERAPEUTICS
- Pericyte–fibroblast transition promotes tumor growth and metastasis
- (2016) Kayoko Hosaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
- (2016) Peng-Hui Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance
- (2016) Fengsheng Li et al. Oncology Letters
- EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
- (2016) C. Depner et al. Nature Communications
- Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
- (2016) Maria Serova et al. Oncotarget
- Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
- (2016) Xiewan Chen et al. Oncotarget
- Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
- (2016) Laura Pisarsky et al. Cell Reports
- Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
- (2016) Elizabeth A. Kuczynski et al. JNCI-Journal of the National Cancer Institute
- Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies
- (2016) Antonia Reale et al. Stem Cells International
- Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
- (2016) Rikke B. Holmgaard et al. EBioMedicine
- Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux
- (2015) Sandy Giuliano et al. Autophagy
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality
- (2015) A. McIntyre et al. EMBO Molecular Medicine
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
- (2015) A. Schech et al. MOLECULAR CANCER THERAPEUTICS
- Immunogenic, cellular, and angiogenic drivers of tumor dormancy-a melanoma view
- (2015) Daniela Senft et al. Pigment Cell & Melanoma Research
- Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression
- (2015) Dong Tang et al. TUMOR BIOLOGY
- Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
- (2015) Atsushi Mitsuhashi et al. Nature Communications
- Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
- (2015) Ki-Eun Hwang et al. Oncotarget
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Galectin-1 Pulls the Strings on VEGFR2
- (2014) Pamela Stanley CELL
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
- (2014) Nor Eddine Sounni et al. Cell Metabolism
- A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
- (2014) Matthew A. Powell et al. GYNECOLOGIC ONCOLOGY
- Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study
- (2014) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
- (2014) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- The Autophagic Response to Radiation: Relevance for Radiation Sensitization in Cancer Therapy
- (2014) David A. Gewirtz RADIATION RESEARCH
- Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism
- (2014) Florent Morfoisse et al. Cell Reports
- Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy
- (2014) Erez Hasnis et al. NEOPLASIA
- Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
- (2013) Gregg L. Semenza Annual Review of Pathology-Mechanisms of Disease
- Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis
- (2013) Zhifei Cao et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis
- (2013) T Osawa et al. BRITISH JOURNAL OF CANCER
- Hyaluronan, fluid pressure and stromal resistance in pancreas cancer
- (2013) P P Provenzano et al. BRITISH JOURNAL OF CANCER
- 1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond
- (2013) A. Jahangiri et al. CANCER RESEARCH
- 1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
- (2013) W. S. Carbonell et al. CANCER RESEARCH
- The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
- (2013) R. Grepin et al. CANCER RESEARCH
- Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
- (2013) Ya-Ling Hsu et al. CARCINOGENESIS
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
- (2013) Lin Cheng et al. CELL
- Targeting Activated Akt with GDC-0068, a Novel Selective Akt Inhibitor That Is Efficacious in Multiple Tumor Models
- (2013) J. Lin et al. CLINICAL CANCER RESEARCH
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Cell Trafficking of Endothelial Progenitor Cells in Tumor Progression
- (2013) P. de la Puente et al. CLINICAL CANCER RESEARCH
- Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
- (2013) Y. Kienast et al. CLINICAL CANCER RESEARCH
- Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels
- (2013) Scott K. Parks et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
- (2013) Krishan Kumar et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
- (2013) Robert J Motzer et al. LANCET ONCOLOGY
- A Proangiogenic Signature Is Revealed in FGF-Mediated Bevacizumab-Resistant Head and Neck Squamous Cell Carcinoma
- (2013) R. Gyanchandani et al. MOLECULAR CANCER RESEARCH
- Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2
- (2013) Anna C. Navis et al. PLoS One
- A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors
- (2013) Markus Thomas et al. PLoS One
- The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
- (2013) G. Thurston et al. Cold Spring Harbor Perspectives in Medicine
- Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer
- (2013) Minal Garg World Journal of Stem Cells
- Contrasting effects of sunitinib within in vivo models of metastasis
- (2012) Jonathan C. Welti et al. ANGIOGENESIS
- Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
- (2012) K Yamamoto et al. BRITISH JOURNAL OF CANCER
- Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
- (2012) Vesselina G. Cooke et al. CANCER CELL
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- Angiopoietins in angiogenesis
- (2012) Ernesta Fagiani et al. CANCER LETTERS
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- (2012) A. N. Brooks et al. CLINICAL CANCER RESEARCH
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
- (2012) Federica Maione et al. JOURNAL OF CLINICAL INVESTIGATION
- Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis
- (2012) Yuan Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors
- (2012) Alicia S Chung et al. JOURNAL OF PATHOLOGY
- Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models
- (2012) Mallika Singh et al. JOURNAL OF PATHOLOGY
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Metabolic symbiosis in cancer: Refocusing the Warburg lens
- (2012) Erica C. Nakajima et al. MOLECULAR CARCINOGENESIS
- Keeping fit with autophagy
- (2012) Rachel David NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
- (2012) Y. Piao et al. NEURO-ONCOLOGY
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
- (2012) S. J. Conley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
- (2011) Roberta Mazzieri et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis: Figure 1.
- (2011) Michele De Palma et al. CLINICAL CANCER RESEARCH
- TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
- (2011) Laurens A. van Meeteren et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
- (2011) Satoshi Shimizu et al. INTERNATIONAL JOURNAL OF CANCER
- Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
- (2011) Marie Jeansson et al. JOURNAL OF CLINICAL INVESTIGATION
- Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma
- (2011) Tina Cascone et al. JOURNAL OF CLINICAL INVESTIGATION
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines
- (2011) R Grepin et al. ONCOGENE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Gene expression and hypoxia in breast cancer
- (2011) Elena Favaro et al. Genome Medicine
- Platelet-derived growth factor signaling in human malignancies
- (2011) Kun-Wei Liu et al. Chinese Journal of Cancer
- Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
- (2010) V Goede et al. BRITISH JOURNAL OF CANCER
- Endothelial Progenitor Cells: Hope Beyond Controversy
- (2010) E. Pasquier et al. CURRENT CANCER DRUG TARGETS
- Hypoxia and energetic tumour metabolism
- (2010) M Christiane Brahimi-Horn et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
- (2010) J. L. Brown et al. MOLECULAR CANCER THERAPEUTICS
- Stromal Cell-Derived Factor-1/CXCL12 Contributes to MMTV-Wnt1 Tumor Growth Involving Gr1+CD11b+ Cells
- (2010) Bob Y. Liu et al. PLoS One
- Signaling by members of the TGF-β family in vascular morphogenesis and disease
- (2010) Evangelia Pardali et al. TRENDS IN CELL BIOLOGY
- The bevacizumab experience in advanced renal cell carcinoma
- (2010) Lauren Harshman OncoTargets and Therapy
- Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
- (2009) Elena I. Deryugina et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
- (2009) I. Helfrich et al. CLINICAL CANCER RESEARCH
- Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
- (2009) Y.-Q. Xiong et al. CLINICAL CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
- (2009) Annamaria Rapisarda et al. DRUG RESISTANCE UPDATES
- Imaging glioma cell invasionin vivoreveals mechanisms of dissemination and peritumoral angiogenesis
- (2009) Frank Winkler et al. GLIA
- Targeting transforming growth factor (TGF)-βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma
- (2009) Emilia Fransvea et al. HEPATOLOGY
- Transforming growth factor-beta 1 (TGF-β1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis
- (2009) Giovanni Ferrari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Antiangiogenic therapies for high-grade glioma
- (2009) Andrew D. Norden et al. Nature Reviews Neurology
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies
- (2009) Yongping Crawford et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- Refractoriness to Antivascular Endothelial Growth Factor Treatment: Role of Myeloid Cells
- (2008) F. Shojaei et al. CANCER RESEARCH
- Vascular Endothelial Growth Factor Receptor 2 Mediates Macrophage Infiltration into Orthotopic Pancreatic Tumors in Mice
- (2008) S. P. Dineen et al. CANCER RESEARCH
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
- Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
- (2008) Ilaria Marigo et al. IMMUNOLOGICAL REVIEWS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started